J. Kupryjanczyk et al., Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction, BR J CANC, 82(3), 2000, pp. 579-583
Changes in cell survival contribute to tumour development, influence tumour
biology and its response to chemotherapy. p53 gene alterations should nega
tively affect apoptosis by impaired p53-dependent apoptotic response. We lo
oked for associations between spontaneous apoptosis, p53 gene mutation, p53
protein accumulation, growth fraction, bcl-2 expression and histological p
arameters in 64 ovarian, four tubal and three peritoneal carcinomas. Apopto
tic cells were detected with the TUNEL method. p53 gene Variants were detec
ted by the single-strand conformation polymorphism and were sequenced direc
tly. P53, Ki-67 and bcl-2 protein expressions were detected immunohistochem
ically. A weighed multiple logistic regression model was applied. Apoptotic
index (Al) ranged 0.02-0.18 (mean 0.11); proliferation index (PI) ranged 3
-90% (mean 54%). p53 gene mutations were present in 51, p53 protein accumul
ation in 46, and diffuse bcl-2 expression in 29 of 71 tumours. The Al was p
ositively associated with the presence of p53 gene mutation (P = 0.011). Ho
wever, the PI included into the analysis did positively influence the Al (P
= 0.02) and diminished the association with p53 gene mutation (P = 0.082).
The Al was negatively associated with good histological differentiation (P
= 0.0006), the serous tumour type (P = 0.002), and diffuse bcl-2 expressio
n (P = 0.025). Strong bcl-2 expression was associated with endometrioid tum
our type (P = 0.002). FIGO stage and p53 protein accumulation were the only
parameters that influenced overall survival time. Thus, our results sugges
t that histological tumour type and grade are major determinants of spontan
eous apoptosis in ovarian carcinomas; p53 alterations do not adversely but
rather positively affect spontaneous apoptosis by increasing growth fractio
n. This, in turn, suggests p53-independency of spontaneous apoptosis in ova
rian carcinomas. (C) 2000 Cancer Research Campaign.